PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29852388-9	2018	Moreover, cells with decreased Grp94 levels displayed an enhanced sensitivity of tumor cells to doxorubicin, a standard drug in the treatment of breast cancer.	Doxorubicin	96-107	heat shock protein 90 beta family member 1	Homo sapiens	31-36	
19205439-0	2008	Increased expression of GRP94 protein is associated with decreased sensitivity to adriamycin in ovarian carcinoma cell lines.	Doxorubicin	82-92	heat shock protein 90 beta family member 1	Homo sapiens	24-29	
19205439-6	2008	RESULTS: HO-8910PM cells, with the highest basal levels of GRP94, exhibited the lowest sensitivity to adriamycin.	Doxorubicin	102-112	heat shock protein 90 beta family member 1	Homo sapiens	59-64	
19205439-7	2008	In HO-8910PM cells, the sensitivity to adriamycin was increased when the GRP94 gene was disturbed by specific siRNA transfection.	Doxorubicin	39-49	heat shock protein 90 beta family member 1	Homo sapiens	73-78	
19205439-8	2008	CONCLUSIONS: High GRP94 expression might be one of the molecular mechanisms causing resistance to adriamycin, and therefore GRP94 siRNA maybe useful in tumor-specific gene therapy in ovarian cancer.	Doxorubicin	98-108	heat shock protein 90 beta family member 1	Homo sapiens	18-23